| Literature DB >> 35911022 |
Tasneem Hassem1, Sumaya Laher1.
Abstract
Despite the rapid growth in digital mental health options, a systematic review conducted on the ethics of developing online mental health screening instruments highlighted that there were no formal guidelines in this area. This lack of formal guidelines and the results of the systematic review led to the development of formal guidelines for online mental health screening tools in South Africa. This study aimed to explore the efficacy of these draft guidelines using a qualitative design with two samples of individuals recognised as experts in the field of mental health. Sample one consisted of a purposive sample of 15 experts who commented on the appropriateness of the draft guidelines. The second sample consisted of 9 experts who completed the Appraisal of Guidelines for Research and Evaluation (AGREE) instrument to assess the guidelines. Both samples were in agreement on the relevance of the core content areas in the guidelines, namely purpose and scope, modes of testing, psychometric properties, informed consent, ensuring minimal risk to participants, feedback as well as data security. There was also agreement on the appropriateness of the methods used to develop the guidelines. The use of the guidelines was supported with the suggestion that issues of risk and suicidality be explored further.Entities:
Keywords: AGREE; ethics; mental health; online screening; telehealth
Year: 2022 PMID: 35911022 PMCID: PMC9331289 DOI: 10.3389/fpsyg.2022.875911
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1Guideline development process.
Overview of the guidelines document.
| 1. Introduction | 6. Acknowledgements |
| 2. Aim | 7. Competing interest |
| 3. Objectives | 8. Funding |
| 4. Who are the guidelines for? | 9. Disclaimer |
| 5. Process of guideline development: | 10. Guidelines for developing an open mode online mental health screening tool |
| 5.1. Systematic Review | 10.1. Purpose or scope |
| 5.2. Development of draft guidelines | 10.2. Modes of testing |
| 5.3. Expert input | 10.3. Psychometric properties |
| 5.4. Revision | 10.4. Informed consent |
| 5.5. Guideline appraisal | 10.5. Ensuring minimal risk to participants |
| 5. 6. Revisions | 10.6. Feedback |
| 5.7. Procedures for updating the guidelines | 10.7. Data security |
| 11. References |
Frequency responses obtained on the AGREE tool.
| Item | 1 | 2 | 3 | 4 | 5 | 6 | 7 | N/A |
|
| ||||||||
| 1. The overall objective(s) of the guideline is(are) specifically described | 1 | 1 | 2 | 5 | ||||
| 2. The Health question(s) covered by the guideline is(are)specifically described | 2 | 2 | 2 | 1 | 2 | |||
| 3. The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described | 1 | 1 | 2 | 3 | 2 | |||
|
| ||||||||
| 4. The guideline development group includes individuals from all relevant professional groups | 2 | 3 | 4 | |||||
| 5. The views and preferences of the target population (patients, public, etc.) has been sought | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| 6. The target users of the guidelines are clearly defined | 1 | 2 | 3 | 3 | ||||
|
| ||||||||
| 7. Systematic methods were used to search for evidence | 1 | 2 | 6 | |||||
| 8. The criteria for selecting the evidence are clearly described | 1 | 3 | 5 | |||||
| 9. The strength and limitations of the body of evidence are clearly described | 1 | 1 | 1 | 4 | 2 | |||
| 10. The methods for formulating the recommendations are clearly described | 1 | 3 | 2 | 2 | 1 | |||
| 11. The health benefits, side effects and risks have been considered in formulating the recommendations | 3 | 1 | 3 | 2 | ||||
| 12. There is an explicit link between the recommendations and support evidence | 3 | 3 | 2 | 1 | ||||
| 13. The guidelines have been externally reviewed by experts prior to its publication | 2 | 7 | ||||||
| 14. A Procedure for updating the guideline is provided | 3 | 3 | 1 | 1 | 1 | |||
|
| ||||||||
| 15. The recommendations are specific and unambiguous | 2 | 1 | 3 | 2 | 1 | |||
| 16. The different options for management of the condition or health issues are clearly presented | 1 | 1 | 1 | 2 | 1 | 3 | ||
| 17. Key recommendations are easily identifiable | 3 | 4 | 1 | 1 | ||||
|
| ||||||||
| 18. The guideline describes facilitators and barriers to its application | 1 | 4 | 2 | 2 | ||||
| 19. The guideline provides advice and/or tools on how the recommendations can be put into practice | 1 | 3 | 2 | 3 | ||||
| 20. The potential resource implications of applying the recommendations have been considered | 1 | 4 | 2 | 1 | 1 | |||
| 21. The guidelines presents monitoring and/or auditing criteria | 2 | 4 | 1 | 2 | ||||
|
| ||||||||
| 22. The views of the funding body have not influenced the content of the guidelines | 1 | 5 | 3 | |||||
| 23. Competing interests of the guideline development group members have been recorded and addressed. | 1 | 4 | 2 | 1 | 1 | |||
|
| ||||||||
| 24. Rate the quality of the guideline | 1 | 3 | 4 | 1 | ||||
| 25. I would recommend this guideline for use | Yes ( | Yes, with modification ( | No ( | |||||
*1 represents strongly disagree and 7 strongly agree.
FIGURE 2A graphical representation of the means and standard deviations for each AGREE item.